A randomized, crossover study to determine bioequivalence of S-Etodolac ER tablets versus Etodolac ER tablets in healthy Indian subjects.
Objective To estimate the bioavailability and evaluate bioequivalence of S-Etodolac 300 mg tablet and to compare it with that of Etodolac 600 mg tablet Materials and Methods Using a two-treatment, two-period, twosequence, randomized crossover design, test and reference formulations were administered...
| Publicado en: | Journal of Applied Research Vol. 9; no. 3; pp. 57 - 63 |
|---|---|
| Autores principales: | , , , , |
| Formato: | research Journal Article |
| Publicado: |
Therapeutic Solutions LLC
2009
|
| Acceso en línea: | Ver este registro en EBSCOhost |